TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL RADIATION ONCOLOGY MARKET, BY TYPE
6.1. Overview
6.2. External Beam Radiation Therapy
6.3. Internal Beam Radiation Therapy
7. GLOBAL RADIATION ONCOLOGY MARKET, BY APPLICATION
7.1. Overview
7.2. Prostate Cancer
7.3. Breast Cancer
7.4. Lung Cancer
7.5. Head and Neck Cancer
7.6. Colorectal Cancer
7.7. Cervical Cancer
7.8. Gynecological Cancer
7.9. Others
8. GLOBAL RADIATION ONCOLOGY MARKET, BY REGION
8.1. Overview
8.1. North America
8.1.1. US
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. France
8.2.3. UK
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia-Pacific
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. South Korea
8.3.5. Australia
8.3.6. Rest of Asia-Pacific
8.4. Rest of the World
8.4.1. Middle East
8.4.2. Africa
8.4.3. Latin America
9. COMPETITIVE LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global Radiation Oncology Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Global Radiation Oncology Market,
9.7. Key developments and Growth Strategies
9.7.1. New Product Launch/Service Deployment
9.7.2. Merger & Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2022
9.8.2. Major Players R&D Expenditure. 2022
10. COMPANY PROFILES
10.1. Isoray Inc.
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Products Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Provision Healthcare
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Products Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. IBA Worldwide
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Products Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. Accuray Incorporated
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Products Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Varian Medical Systems
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Products Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. Elekta AB
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Products Offered
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. BD
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Products Offered
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. Panacea Medical Technologies Pvt. Ltd
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Products Offered
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. Nordion (Canada) Inc.
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Products Offered
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. Mevion Medical Systems
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Products Offered
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
11. APPENDIX
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL RADIATION ONCOLOGY MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL RADIATION ONCOLOGY MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL RADIATION ONCOLOGY MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL RADIATION ONCOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 5 NORTH AMERICA: RADIATION ONCOLOGY MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: RADIATION ONCOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 7 US: RADIATION ONCOLOGY MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 8 US: RADIATION ONCOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 9 CANADA: RADIATION ONCOLOGY MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 10 CANADA: RADIATION ONCOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 1 EUROPE: RADIATION ONCOLOGY MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 2 EUROPE: RADIATION ONCOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 3 GERMANY: RADIATION ONCOLOGY MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 4 GERMANY: RADIATION ONCOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 5 FRANCE: RADIATION ONCOLOGY MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 6 FRANCE: RADIATION ONCOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 7 ITALY: RADIATION ONCOLOGY MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 8 ITALY: RADIATION ONCOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 9 SPAIN: RADIATION ONCOLOGY MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 10 SPAIN: RADIATION ONCOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 11 UK: RADIATION ONCOLOGY MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 12 UK: RADIATION ONCOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 13 REST OF EUROPE: RADIATION ONCOLOGY MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 14 REST OF EUROPE: RADIATION ONCOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 15 ASIA-PACIFIC: RADIATION ONCOLOGY MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 16 ASIA-PACIFIC: RADIATION ONCOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 17 JAPAN: RADIATION ONCOLOGY MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 18 JAPAN: RADIATION ONCOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 19 CHINA: RADIATION ONCOLOGY MARKET, BY TYPE, 2018-2032 (USD BILLION)
CHINA: RADIATION ONCOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 20 INDIA: RADIATION ONCOLOGY MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 21 INDIA: RADIATION ONCOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 22 AUSTRALIA: RADIATION ONCOLOGY MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 23 AUSTRALIA: RADIATION ONCOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 24 BILLION)
TABLE 25 SOUTH KOREA: RADIATION ONCOLOGY MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 26 SOUTH KOREA: RADIATION ONCOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 27 BILLION)
TABLE 28 REST OF ASIA-PACIFIC: RADIATION ONCOLOGY MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 29 REST OF ASIA-PACIFIC: RADIATION ONCOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 30 REST OF THE WORLD: RADIATION ONCOLOGY MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 31 REST OF THE WORLD: RADIATION ONCOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 32 MIDDLE EAST: RADIATION ONCOLOGY MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 33 MIDDLE EAST: RADIATION ONCOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 34 AFRICA: RADIATION ONCOLOGY MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 35 AFRICA: RADIATION ONCOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 36 LATIN AMERICA: RADIATION ONCOLOGY MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 37 LATIN AMERICA: RADIATION ONCOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL RADIATION ONCOLOGY MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL RADIATION ONCOLOGY MARKET
FIGURE 4 GLOBAL RADIATION ONCOLOGY MARKET, SHARE (%), BY TYPE, 2022
FIGURE 5 GLOBAL RADIATION ONCOLOGY MARKET, SHARE (%), BY APPLICATION, 2022
FIGURE 6 GLOBAL RADIATION ONCOLOGY MARKET, SHARE (%), BY REGION, 2022
FIGURE 7 NORTH AMERICA: RADIATION ONCOLOGY MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 EUROPE: RADIATION ONCOLOGY MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 ASIA-PACIFIC: RADIATION ONCOLOGY MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 REST OF THE WORLD: RADIATION ONCOLOGY MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 GLOBAL RADIATION ONCOLOGY MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 12 ISORAY INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 ISORAY INC.: SWOT ANALYSIS
FIGURE 14 PROVISION HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 PROVISION HEALTHCARE: SWOT ANALYSIS
FIGURE 16 IBA WORLDWIDE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 IBA WORLDWIDE: SWOT ANALYSIS
FIGURE 18 ACCURAY INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 ACCURAY INCORPORATED: SWOT ANALYSIS
FIGURE 20 VARIAN MEDICAL SYSTEMS.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 VARIAN MEDICAL SYSTEMS.: SWOT ANALYSIS
FIGURE 22 ELEKTA AB: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 ELEKTA AB: SWOT ANALYSIS
FIGURE 24 BD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 BD: SWOT ANALYSIS
FIGURE 26 PANACEA MEDICAL TECHNOLOGIES PVT. LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 PANACEA MEDICAL TECHNOLOGIES PVT. LTD: SWOT ANALYSIS
FIGURE 28 NORDION (CANADA) INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 NORDION (CANADA) INC.: SWOT ANALYSIS
FIGURE 30 MEVION MEDICAL SYSTEMS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 MEVION MEDICAL SYSTEMS: SWOT ANALYSIS